Rollins School of Public Health | Faculty Profile

Please help improve Faculty Profile solution by taking a quick Survey


Emory Rollins School of Public Health
Return to Faculty Listing

Abhinav  Goyal

Assoc Professor

Professor

Jointly Appointed, Epidemiology

Abhinav Goyal, MD, MHS, FACC, FAHA is an academic cardiologist and clinical investigator who is a Professor of Medicine (Division of Cardiology) at the Emory School of Medicine, with a joint appointment in the Department of Epidemiology at Emory Rollins School of Public Health.  Dr. Goyal also serves as the Chief Quality Officer for the Emory Heart and Vascular Center.  He is responsible for directing all quality-related initiatives in the Emory Heart and Vascular Center, including providing physician oversight for Emory Hospitals' participation in the American College of Cardiology National Cardiovascular Data Registry (CathPCI Registry and LAAO Registry); American Heart Association (AHA) GWTD-CAD Registry and  Mission: Lifeline program for patients with acute heart attacks; AHA COVID-19 Registry; and The Emory Clinic's quality improvement initiatives pertaining to cardiovascular performance measures.  Dr. Goyal’s research interests include population research investigating the link between diabetes or dysglycemia and cardiovascular disease; quality, health services research, and outcomes research in cardiovascular medicine; classification and management of acute myocardial infarction; and cardiovascular clinical trials.

 

To learn more about Dr. Goyal's clinical, research, service, and teaching contributions, please click on the "Curriculum Vitae" link below, or visit the link

http://scholar.google.com/citations?user=A5JS8dkAAAAJ

View Resume

Contact Information

1462 Clifton Rd NE , Room 531

Atlanta , GA 30322

Room 531

Phone: 404-727-8758

Fax: 404-727-6495

Email: AGOYAL4@EMORY.EDU

Update Profile

Areas of Interest

  • Cardiovascular Diseases
  • Diabetes
  • Health Outcomes

Education

  • MD 1999, Northwestern University Medical School
  • MHS (Masters in Health Sciences) 2006, Duke University
  • Internal Medicine Residency 2002, University of Pennsylvania Medical Center
  • Cardiology Fellowship (Clinical) 2004, Duke University Medical Center
  • Nuclear Cardiology Fellowship (Clinical) 2007, Duke University Medical Center
  • Cardiovascular Research Fellowship 2006, Duke Cliincal Research Institute
  • Cardiovascular Research Fellowship 2007, Population Health Res. Inst., McMaster Univ

Publications

  • , , Health system-wide quality programs to improve blood pressure control, JAMA, 310, 695-6
  • , , Serum potassium levels and mortality in acute myocardial infarction, JAMA, 307, 157-64
  • , , Piloting a novel algorithm for glucose control in the CCU: the RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) Trial., Diabetes Care, , doi: 10.2337/dc11-0706
  • , , Attained educational level and incident atherothrombotic events in low-and-middle income compared with high-income countries., Circulation, 122, 1167-75
  • , , Predictors of incident heart failure in a large insured population: a one million person-year follow-up study, Circulation: Heart Failure, 3, 698-705
  • , , Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction. , Circulation, 120, 2429-2437
  • , , Glucose normalization and outcomes in patients hospitalized with acute myocardial infarction – defining the optimal glucose target range., Arch Intern Med, 169, 438-446
  • , , The relationship between spontaneous and iatrogenic hyperglycemia and mortality in patients hospitalized with acute myocardial infarction., JAMA, 301, 1556-1564
  • , , Insulin therapy in acute coronary syndrome: a current appraisal of completed and ongoing randomized trials with important clinical endpoints., Diabetes Vasc Dis Res, 5, 276-84
  • , , Glucose-insulin-potassium (GIK) therapy in patients with ST-segment elevation myocardial infarction., JAMA, 298, 2399-2405
  • , , Outcomes associated with the use of secondary prevention medications following coronary artery bypass graft surgery., Ann Thorac Surg, 83, 993-1001
  • , , Prognostic significance of the change in glucose in first 24 hours after acute myocardial infarction: results from the CARDINAL study., Eur Heart J, 27, 1289-97
  • , , The burden of cardiovascular disease in the Indian subcontinent. , Indian J Med Res , 124, 235-44
  • , , Efficacy and safety of edifoligide, an E2F transcription factor decoy, for the prevention of vein graft failure following coronary artery bypass graft surgery., JAMA, 294, 2446-54
  • , , To view complete list of publications, please click on "View Resume" link above., , ,